PubRank

Christian Brambilla

Author PubWeight™ 78.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011 21.49
2 Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2010 6.39
3 Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012 5.28
4 Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov 2011 4.80
5 Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst 2009 2.16
6 ING2 controls the G1 to S-phase transition by regulating p21 expression. Cell Cycle 2010 2.06
7 Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med 2013 1.79
8 Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect 2011 1.79
9 Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011 1.78
10 Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol 2013 1.71
11 Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007 1.68
12 WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res 2009 1.39
13 Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer. Clin Cancer Res 2008 1.31
14 The new tumor suppressor genes ING: genomic structure and status in cancer. Int J Cancer 2008 1.30
15 Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO J 2010 1.23
16 Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol 2003 1.20
17 Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study. PLoS One 2010 1.18
18 Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. J Clin Oncol 2012 1.06
19 Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. J Pathol 2003 1.05
20 Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002 1.03
21 Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy. Chest 2002 1.02
22 Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort. Eur Respir J 2012 1.01
23 Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Oncogene 2002 0.98
24 p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation. Cell Cycle 2006 0.93
25 Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J Biol Chem 2005 0.92
26 Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. Am J Respir Crit Care Med 2008 0.92
27 CT-guided biopsy of nonresolving focal air space consolidation. J Thorac Imaging 2008 0.89
28 Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions. Clin Cancer Res 2005 0.89
29 Chemical constituents of diesel exhaust particles induce IL-4 production and histamine release by human basophils. J Allergy Clin Immunol 2002 0.87
30 The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis. Future Oncol 2005 0.87
31 SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines. Cell Cycle 2011 0.87
32 Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity. Transpl Immunol 2002 0.87
33 Expression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 [Flt-1] and VEGF-R2 [KDR/Flk-1]) in tumorlets and in neuroendocrine cell hyperplasia of the lung. Hum Pathol 2004 0.85
34 Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 2003 0.84
35 Pulmonary nodules with the CT halo sign. Respiration 2002 0.84
36 Telomere maintenance and DNA damage responses during lung carcinogenesis. Clin Cancer Res 2010 0.84
37 Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in Europe. Eur J Cancer 2009 0.83
38 Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals. Environ Health 2012 0.82
39 ING2 controls the progression of DNA replication forks to maintain genome stability. EMBO Rep 2009 0.80
40 Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project. Int J Oncol 2010 0.79
41 Progressive lung cancer determined by expression profiling and transcriptional regulation. Int J Oncol 2012 0.79
42 Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients. Lung Cancer 2012 0.78
43 Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma. Lung Cancer 2009 0.77
44 Impact of molecular pathology on the clinical management of lung cancer. Respiration 2005 0.75
45 Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study. BMC Cancer 2014 0.75
46 [Management of acute community-acquired pneumonia in a health centre. Assessment of 101 cases using the retrospective clinical audit method]. Presse Med 2003 0.75